National Vaccine Advisory Committee A Status Report on the Pediatric Vaccine Stockpiles Pediatric Vaccine Stockpiles February 8, 2005 Eddie Wilder Project.

Slides:

Advertisements

Similar presentations

©Tariff Check Services Ltd Questions ??? Are you in control of your mobile phone usage and expenditure? Are you getting the best rates from your.

Advertisements

1 Cover page Let’s Review Changes in CDC Recommendations in 2011 Carolee’s Corner January 2012 MPCA

ACIP Meeting Update November 4 th

1. 2 The Public Health Agency of Canada Pandemic Influenza Preparedness: An Overview Dr. Paul Gully Deputy Chief Public Health Officer Ottawa, 19 January.

To protect the health and environment of all Kansans by promoting responsible choices. Immunization Program 2009 H1N1 Adventure Governor’s Child Health.

Registry Support of Immunization Program Activities Lance Rodewald, M.D. Director Immunization Services Division, NIP/CDC Bill Brand, M.P.H. Vice-President,

INDEPENDENT REGULATORY BOARD FOR AUDITORS Bernard Agulhas Chief Executive Officer 1 Select Committee on Finance 20 June 2012.

National Immunization Program Report NVAC Washington, DC  February 3-4, 2004 Stephen L. Cochi, M.D., M.P.H. Acting Director, National Immunization Program.

A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.

The National Vaccine Plan Process - Update October 22, 2007 Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services.

Title V Fee Committee: Answers to July 2013 Questions September 11, 2013.

Portfolio Committee Presentation Government printing Works Audit and Compliance 07 May 2013 Presented by: Chief Executive Officer.

Shelf Life Extension Program (SLEP)

University of Massachusetts Boston FY11 Budget Process February 25, 2010.

Vaccines for Children Program Stockpile Status National Vaccine Advisory Committee February 4, 2010 Washington, DC Lance E Rodewald, MD Director, Immunization.

Needs and Recommendations for the United States Poliovirus Vaccine Stockpile Report of the Joint Working Group of the National Vaccine Advisory Committee.

IOM Report on Financing Vaccines in the 21 st Century: National Vaccine Advisory Committee Follow-up Alan R. Hinman, MD, MPH Chair, NVAC Workgroup on IOM.

Implementing New Vaccines and Vaccine Recommendations National Vaccine Advisory Committee Washington, DC September 26, 2006 Lance E. Rodewald, MD Director,

Vaccine Supply Update Jeanne M. Santoli Vaccine Supply and Assurance Branch January 22, 2010.

REQUIREMENTS ANALYSIS: Developing a Near-term Plan for Washington’s Statewide Immunization Registry Janna Halverson, Sherry Riddick, Belinda Baker.

U.S. Pandemic Influenza Preparedness and Response: Update & Progress Report “The pandemic influenza clock is ticking. We just don’t know what time it is.”

University of Central Florida Assessment Toolkit for Academic, Student and Enrollment Services Dr. Mark Allen Poisel Dr. Ron Atwell Dr. Paula Krist Dr.

A Potential Influenza Pandemic: Possible Macroeconomic Effects and Policy Issues Julie Somers Congressional Budget Office Prepared for the Ninth Annual.

Childhood Vaccine Financing: Implications for States National Vaccine Advisory Committee November 29, 2005 Washington, DC Lance E. Rodewald, MD Director,

INTERNAL AUDIT AND INVESTIGATION SERVICES PRESENTATION TO THE PORTFOLIO COMMITTEE ON THE UNIT’S ACTIVITIES FOR THE YEAR ENDING 31 MARCH 2006 Z MXUNYELWA,

State Health Agency Perspectives on the Implementation of New Vaccines Presentation to the National Vaccine Advisory Committee September 26, 2006 Calvin.

Polio Eradication -- Global Progress and Development of Post-Eradication Strategies: Implications for U.S. Stockpile and Outbreak Response Preparations.

UNIVERSITY BUDGET ADVISORY COUNCIL CALIFORNIA STATE UNIVERSITY, SAN BERNARDINO MEETING AGENDA OCTOBER 31, 2008.

July 19, 2005 Walter A. Orenstein, M.D. Professor of Medicine Director, Emory Vaccine Policy and Development Associate Director, Emory Vaccine Center Purchase.

National Vaccine Advisory Committee Report from the Chair Gus Birkhead, MD, MPH NVAC Chair June 2, 2010.

PEDIATRIC VACCINE STOCKPILES A Status Report on the Pediatric Vaccine Stockpiles November 2005 Gregory S. Wallace, M.D., M.S., M.P.H. Chief, Program Support.

OIRM Business Process Planning Overview for Business & Operations Advisory Committee May 27 – 28, 2015.

AMC Governance and Institutional Support. Objectives Build on existing capacity Ensure appropriate independence and credibility through transparency,

TM OPV Stockpiling in the United States Trudy V. Murphy, M.D. National Immunization Program Centers for Disease Control and Prevention February 5, 2003.

Planning for the Influenza Season: Will it be Rain, Shine, or Hurricane? National Vaccine Advisory Committee June 7, 2005 Washington, DC Raymond.

2005 AHIP Immunization Assessment Summary National Vaccine Advisory Committee November 29-30, 2005 Steve Black, MD, AHIP Liaison to NVAC Bob Rehm, Director.

National Vaccine Advisory Committee Report from the Chair Gus Birkhead, MD, MPH NVAC Chair February 3, 2010.

A Vaccine Supply Update For The U.S. Market A Presentation At The National Vaccine Advisory Committee Meeting June 3, 2003 Dean Mason Chief, Program Support.

(Slide 1 of 22) Response to the National Vaccine Advisory Committee Recommendations on the Immunization Safety Office Scientific Agenda Frank DeStefano,

Strategies to Consider to Improve ACCV Effectiveness Presentation to ACCV Vito Caserta M.D., M.P.H. Vincent Matanoski, J.D. December 5,

Securing the Supply of Condoms and Other Essential Products for HIV/AIDS Programs Tony Hudgins Yasmin Chandani John Snow Research & Training Institute.

University of Minnesota Internal\External Sales “The Internal Sales Review Process” An Overview of What Happens During the Review.

Getting The Job Done Safe Vaccine Storage and Handling in a busy pediatric practice Speaker: Barbara Turner, RN, BSN Vaccine Manager North Fulton Pediatrics,

A Vaccine Supply Update For The U.S. Market A Presentation At National Advisory Committee Meeting February 4, 2003 Dean Mason Chief, Program Support Branch.

OVERVIEW OF THE NATIONAL INFLUENZA VACCINE SUMMIT Dennis J. O’Mara Associate Director for Adult Immunization Immunization Services Division National Immunization.

VFC Pediatric Vaccine Stockpile National Vaccine Advisory Committee October 23, 2007 Gregory S. Wallace, M.D., M.S., M.P.H. Chief, Vaccine Supply and Assurance.

Planning for the Influenza Season National Vaccine Advisory Committee February 8, 2005 Washington, DC Lance E. Rodewald, MD Director, Immunization.

1 NVAC Washington, D.C. February 3, Agenda I.Overview of Influenza Vaccine Production and Development II.Vaccine Supply/Demand: Recent Trends.

Implementation of the Pandemic and All-Hazards Preparedness Act Briefing for National Vaccine Advisory Commitee February 5, 2007 By: Brian Kamoie Acting.

Highlights of Recent Results from the New Health Insurance Modules of the National Immunization Survey National Vaccine Advisory Committee October 22,

Adult Immunization: Goals, Challenges, and a role for the National Vaccine Advisory Committee October 22, 2007 Raymond A. Strikas, MD National Vaccine.

Update from the Office of Vaccines Research and Review, CBER/FDA NVAC Meeting Washington, D.C. February 4-5, 2003.

CDC VACCINE STOCKPILE FISCAL AND MANAGEMENT ISSUES A Presentation At The National Vaccine Advisory Committee Meeting February 4, 2003 Kimberly S. Lane.

National Immunization Program (NIP)/Advisory Committee on Immunization Practices (ACIP) Report Stephen L. Cochi, MD, MPH Acting Director, National Immunization.

Bee Wise Immunize Governor’s Child Health Advisory Committee Immunization Workgroup Topeka, KS November 19, 2010 Sue Bowden, RN, BS Director, KDHE Immunization.

Carol Friedman, D.O. Associate Director for Adult Immunization Immunization Services Division National Center for Immunization and Respiratory Diseases.

SNIC, NIC Connecting the Connectors: Bringing Together Business Coalitions, Employers, Health Plans, Pediatricians and Public Health Pam Beal Southern.

Evaluation of the 2004 pneumococcal conjugate vaccine shortage utilizing data from the Michigan Childhood Immunization Registry Norma Allred, PhD, John.

Mark V. Francesconi Vaccine Manager, Immunization Program Rhode Island Department of Health.

Georgia Immunization Rates

JON S. ABRAMSON, M.D. DEPARTMENT OF PEDIATRICS

Affordable Energy Production from Renewable Fuel

PROGRESS REPORT ON IMPLEMENTATION OF THE PUBLIC FINANCE MANAGEMENT ACT

Recommended Timeline for Influenza Vaccinations

School Vaccination Requirements

Updating the National Vaccine Plan: A roadmap for the next decade A National, not Federal, Plan December 11, 2009.

Utilizing Immunization Registries in Local Public Health Accreditation

Immunization in the Era of Health Reform: What’s Next?

SCM - Demand Management Eliminating Wasteful Exp

March 8, 2006 New ACIP Hepatitis B Recommendations

Presentation transcript:

National Vaccine Advisory Committee A Status Report on the Pediatric Vaccine Stockpiles Pediatric Vaccine Stockpiles February 8, 2005 Eddie Wilder Project Officer, Pediatric Vaccine Stockpile Immunization Services Division (ISD) National Immunization Program (NIP)

Agenda History of Stockpiles History of Stockpiles Current Status of Pediatric Stockpiles Current Status of Pediatric Stockpiles Stockpile Challenges Stockpile Challenges Resolution Options Resolution Options Next Steps Next Steps

Background 01/83Began stockpiling pediatric vaccines 01/83Began stockpiling pediatric vaccines 01/93VFC legislation enacted; established requirement for 6-month stockpile of all routinely recommended childhood vaccines 01/93VFC legislation enacted; established requirement for 6-month stockpile of all routinely recommended childhood vaccines 09/02GAO issues report entitled “Childhood Vaccines, Ensuring an Adequate Supply Poses Continuing Challenges” 09/02GAO issues report entitled “Childhood Vaccines, Ensuring an Adequate Supply Poses Continuing Challenges” 10/02NVAC recommends enhancement of CDC vaccine stockpile 10/02NVAC recommends enhancement of CDC vaccine stockpile

Accomplishments Logistics Management Institute (LMI) work begun Logistics Management Institute (LMI) work begun Broad strategic plan developed Broad strategic plan developed Booz Allen Hamilton (BAH) contract initialized; Vaccine Management Business Improvement Project (VMBIP) ongoing Booz Allen Hamilton (BAH) contract initialized; Vaccine Management Business Improvement Project (VMBIP) ongoing Reached target quantities on MMR and Varicella; partial target quantities of vaccine for Hep A, Hep B, Hib, and e-IPV Reached target quantities on MMR and Varicella; partial target quantities of vaccine for Hep A, Hep B, Hib, and e-IPV

Pediatric Vaccine Stockpile Target Quantities January 2005

Pediatric Vaccine Stockpile Doses Purchased January 2005

Current Status of the Pediatric Vaccine Stockpile January 2005

Current Status of Stockpile Contracts Aventis Aventis Current Storage and Rotation Contract Current Storage and Rotation Contract Purchased product for stockpile Purchased product for stockpile Contract issues Contract issues Merck Merck Current Storage and Rotation Contract Current Storage and Rotation Contract Purchased product for stockpile Purchased product for stockpile Contract issues Contract issues GSK GSK No storage and rotation contract No storage and rotation contract No vaccines delivered to stockpile No vaccines delivered to stockpile Wyeth Wyeth No storage and rotation contract No storage and rotation contract No vaccines delivered to stockpile No vaccines delivered to stockpile

Pediatric Vaccine Stockpile Revenue recognition issues have delayed stockpile build-up progress Revenue recognition issues have delayed stockpile build-up progress SAB 101 has 7 requirements SAB 101 has 7 requirements All four (4) manufacturers are affected by revenue recognition All four (4) manufacturers are affected by revenue recognition HHS has 90-days to develop plan to resolve HHS has 90-days to develop plan to resolve

Pediatric Vaccine Stockpile CDC has developed alternate models CDC has developed alternate models Annual fee model Annual fee model Pros: Pros: Resolves revenue recognition issue with no major operational changes Resolves revenue recognition issue with no major operational changes Easier to manage expiration risk Easier to manage expiration risk Cons: Cons: May result in unreasonable cost to CDC May result in unreasonable cost to CDC May result in accounting constraints at the manufacturer May result in accounting constraints at the manufacturer Requires significant negotiation on value for operating fee Requires significant negotiation on value for operating fee

Pediatric Vaccine Stockpile CDC has developed alternate models CDC has developed alternate models Off-site storage model Off-site storage model Pros: Pros: Resolves revenue recognition issue Resolves revenue recognition issue Provides greater assurance of stockpile availability Provides greater assurance of stockpile availability Cons: Cons: Requires consolidated distribution approach – impacts implementation timing Requires consolidated distribution approach – impacts implementation timing Dramatically increases CDC liability and risks of vaccine expiration Dramatically increases CDC liability and risks of vaccine expiration

Next Steps Resolve revenue recognition issue Resolve revenue recognition issue Review and revise contracts with two (2) manufacturers who have existing stockpile contracts Review and revise contracts with two (2) manufacturers who have existing stockpile contracts Include new manufacturers in stockpile process Include new manufacturers in stockpile process NVAC’s particpation in target quantity workgroup NVAC’s particpation in target quantity workgroup